By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    healthcare cybersecurity
    4 Helpful Tips on How to Protect Your Medical Practice Against Cyber Attacks
    October 24, 2021
    Health Check Diagnosis Medical Condition Analysis Concept
    6 Health Woes With Online Remedies
    January 19, 2022
    Eight Things Men Should Know About the Male Menopause
    Eight Things Men Should Know About the Male Menopause
    April 24, 2022
    Latest News
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
    The Best Home Remedies for Migraines
    June 5, 2025
    The Hidden Impact Of Stress On Your Body’s Alignment And Balance
    May 22, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Does Insurance Cover the Cost of Therapy?
    June 14, 2022
    mental health loss loved one
    Covering Your Own Medical Issues After Losing a Loved One
    July 21, 2024
    healthcare SaaS
    Venture Capital Trends for Healthcare SaaS Platforms
    May 24, 2024
    Latest News
    Cigarette Makers Sue the FDA Over New Labeling Rules
    July 8, 2025
    End-Use Verification: Simple but Potentially Powerful
    July 8, 2025
    How Much do Financial Incentives Matter to Physicians?
    July 8, 2025
    NanoViricides Reports Positive Anti-viral Effect of HIV Drug
    July 8, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Approves Oral Hepatitis C Virus Inhibitor
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > FDA Approves Oral Hepatitis C Virus Inhibitor
Business

FDA Approves Oral Hepatitis C Virus Inhibitor

BarbaraDuck
BarbaraDuck
Share
4 Min Read
SHARE

Hepatitis C is getting some good news as last month another drug went into clinical trials.  Also Merck will include VICTRELIS  in the patient assistance program through which eligible patients may be able to receive product free of charge.  This is the first  new treatment in 20 years.  In the trials more than 65% of the patients were cured, good news there.  The dosage is taken 3 times a day, a pill with meals. 

Hepatitis C is getting some good news as last month another drug went into clinical trials.  Also Merck will include VICTRELIS  in the patient assistance program through which eligible patients may be able to receive product free of charge.  This is the first  new treatment in 20 years.  In the trials more than 65% of the patients were cured, good news there.  The dosage is taken 3 times a day, a pill with meals. 

Boehringer Ingelheim Receives FDA Fast Track Approval for Hepatitis C Virus Treatment and Moves In To Phase 3 Trials

Hepatitis C is the primary cause of liver transplants un the US so sales are predicted to be pretty large with over 3 million in the US having the disease.  One of the benefits of the drug is that the length of time for a cure is less than current treatments.  BD 

WHITEHOUSE STATION, N.J., May 13, 2011 – Merck (NYSE:MRK) (known as MSD outside the United States and Canada) announced today that the U.S. Food and Drug Administration (FDA) has approved VICTRELIS™ (boceprevir), the company’s innovative new medicine for the treatment of chronic hepatitis C (CHC). VICTRELIS is approved for the treatment of CHC genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients (18 years of age and older) with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy.

VICTRELIS is the first in a new class of medicines known as hepatitis C virus (HCV) protease inhibitors approved for use in combination with peginterferon alfa and ribavirin, which is the current standard therapy, for the treatment of chronic hepatitis C.

“Compared to current standard therapy, VICTRELIS can significantly increase a patient’s chance of achieving undetectable levels of the virus, thereby obtaining an SVR. For many patients, VICTRELIS may allow for a shorter total duration of treatment.”

Merck will begin shipping VICTRELIS to pharmacies within a week so that patients will have access to this new medication as soon as possible. In addition, the company is expanding its support of public awareness and education programs for chronic hepatitis C. Resources include coupons to help eligible patients with their medication cost, reimbursement support to help patients understand their insurance coverage for VICTRELIS, and 24/7 nurse phone support.

http://www.merck.com/newsroom/news-release-archive/prescription-medicine-news/2011_0513.html?WT.svl=content&WT.pi=content+Views

More Read

Readmissions: Hard to Predict Who it Will Be and Why
What can we do about overuse of emergency rooms?
The 3 Secrets to Making Your Blog Stand Out
Eagerly Awaiting the Death of Defensive Medicine
Cancer Patients Seeing the Ripple Effects from Sequestration

 

TAGGED:FDAhealth care businesshepatitis C
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Health Care Buzz Today
Business
July 8, 2025
As We Mature (age), Things Change…
Orthopaedics
July 8, 2025
FDA Approves Roche (Genentech) Skin Cancer Drug–Zelboraf
Business
July 8, 2025
Smart Money on Pfizer?
Business
July 8, 2025

You Might also Like

Video: Mobile Point of Care: Choosing Devices for Collaborative Workflows

July 8, 2025
Image
BusinesseHealthMedical InnovationsMobile Health

Health Start-Ups! – The Internet of Things Creeps into Healthcare

July 1, 2013
medical tech
DiagnosticsHospital AdministrationMedical DevicesMedical InnovationsRadiologyTechnology

Customer Service Portal for Medical Equipment Saves Time and Work

March 31, 2014

How Recruitment in Clinical Trials Benefits from a Personalized Approach

March 14, 2015
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?